Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
The burden of asthma multimorbidity in Singapore is severe, with a considerable fraction attributable to OCS-related comorbidities. Policies should aim to reduce excess OCS use and enhance integrated multimorbidity management.
Authors
- Mariko Siyue Koh (ORCID: https://orcid.org/0000-0002-1230-0129)
- Mei Fong Liew (ORCID: https://orcid.org/0000-0002-8880-004X)
- Pei Yee Tiew (ORCID: https://orcid.org/0000-0002-6346-2072)
- Wenjia Chen (ORCID: https://orcid.org/0000-0001-8201-7145)
- Laura Huey Mien Lim (ORCID: https://orcid.org/0009-0005-5384-8632)
- Anthony Yii (ORCID: https://orcid.org/0000-0002-0884-2507)
- David Price (ORCID: https://orcid.org/0000-0002-9728-9992)
- Sanjay H. Chotirmall (ORCID: https://orcid.org/0000-0003-0417-7607)
- John Abisheganaden (ORCID: https://orcid.org/0000-0002-3192-317X)
- Ming‐Ju Tsai (ORCID: https://orcid.org/0000-0003-3621-3334)
- Yah Ru Juang
- Kelvin Bryan Tan
Institutions
- Ministry of Health (SG)
- Kaohsiung Medical University (TW)
- SingHealth (SG)
- National University of Singapore (SG)
- Nanyang Technological University (SG)
- University of Aberdeen (GB)
- Singapore General Hospital (SG)
- Alexandra Hospital (SG)
- Changi General Hospital (SG)
- Tan Tock Seng Hospital (SG)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Observational & Pragmatic Research Institute (SG)
- Duke-NUS Medical School (SG)
- National University Hospital (SG)
- National University Health System (SG)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.waojou.2025.101146
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00